
In a recent announcement aboard Air Force One, President Trump unveiled a bold move aimed at safeguarding the U.S. steel industry: a proposed 25% tariff on all steel and aluminum imports. This latest trade tactic signals a renewed effort to protect American manufacturing, particularly in the wake of concerns about the impact of foreign metals flooding the market.
The news immediately sparked a surge in U.S. steel stocks. Nucor (NUE $135.75, -3.36%) led the pack, soaring 8% in early trading, making it the top performer in the S&P 500 index. Not far behind, Steel Dynamics (STLD $131.40, -3.23%) rose 6%, and U.S. Steel (X $36.96, -2.50%) saw a 4% increase. Investors are clearly banking on the belief that these tariffs will provide a significant boost to the domestic steel industry, which has struggled with competition from lower-cost imports.
While specifics on the tariff plan remain sparse, the proposal is expected to affect key trading partners like Canada and Mexico. Both nations have already felt the sting of tariff threats from the U.S. in recent months, and this new round could deal a substantial blow to their steel and aluminum exports. According to Bloomberg, Canada is the largest exporter of both metals to the U.S., with $11.2 billion in steel and $9.5 billion in aluminum last year. Mexico ranks second for steel exports ($6.5 billion) and third for aluminum ($686 million), making it another key target of these potential tariffs.
The question remains whether China, a dominant player in the global steel market, will face further tariff hikes. Last year, China sold approximately $5 billion worth of steel and $500 million of aluminum to the U.S., but whether these exports will be subjected to additional duties is still unclear. What is certain, however, is that China's influence extends far beyond direct exports to the U.S. With estimates showing China produced roughly 990 million metric tons of steel last year—more than 12 times the U.S. output and nearly half of global production—its impact on global prices is undeniable. China's low-cost steel has long put downward pressure on global markets, making it a central figure in the ongoing tariff saga.
Presented by Turn Therapeutics
When faced with a deadly infection boasting a 70% fatality rate and no existing cure, Bradley Burnam did what most wouldn’t dare—he created the solution himself. Enter Hexagen: a groundbreaking formula that Burnam personally shepherded through the FDA clearance process for just $24,000. But he didn’t stop there. Building on this success, Burnam expanded the technology, secured two additional FDA clearances, and founded a company that’s rewriting the rules on self-made medical innovation: Turn Therapeutics.
Hexagen isn’t just breaking barriers; it’s healing them. Cleared for acute wound care and atopic dermatitis, this powerhouse formula is now on the brink of a bigger leap. Turn, the company behind Hexagen, is paving the way to expand its applications, proving there’s much more to its potential than meets the eye.
Turn just locked in a game-changing commitment—up to $75M in investment from GEM Global Yield Fund. This private equity boost is tied to the company’s plans to go public, setting the stage for Turn to make bold moves in the market spotlight..2
Turn is rolling out institutional, accredited, and unaccredited investors to participate in their current crowdfunding campaign — but only until January 2025.3
The tweet featured a photo with Michael Saylor, the founder of Strategy (formerly MicroStrategy), and sparked a surge of optimism. It seems the market is hoping that Cohen will take a cue from Saylor’s strategy—one that’s famously centered around acquiring large quantities of bitcoin with company cash.
The speculation is tied to GameStop’s impressive cash reserves—currently standing at $4.6 billion in cash and cash-like securities. Traders are now betting that Cohen could follow in Saylor’s footsteps, using those funds to buy bitcoin, a move that has worked wonders for Strategy, even though both companies share a similar operational issue: neither is particularly profitable from its core business operations. GameStop’s revenue model has shifted towards more passive investments, like T-bills, while Strategy has reaped substantial gains from its bitcoin holdings, with a balance sheet increase of about $14 billion.
However, GameStop’s previous venture into the crypto space didn’t quite have the same success. In 2022, the company made headlines by launching a non-fungible token (NFT) marketplace. But after a brief foray into the digital art scene, this initiative fizzled out by early 2024, with the platform closing shortly after Ryan Cohen took the CEO reins in September 2023.
Cohen’s leadership is a key factor in the bullish outlook from major shareholders like Keith Gill, who remains a vocal supporter of the company’s potential. With a history of unconventional strategies, traders are clearly betting that Cohen’s next big move might just involve tapping into the crypto craze in a much more strategic way.
Despite the natural disaster that rattled Taiwan on January 1 and is expected to cause NT$5.3 billion ($160 million) in losses for the first quarter, TSMC remains bullish about its full-year outlook. The company made it clear that while production has been temporarily impacted, it’s taking swift action to recover lost ground.
In a reassuring statement, TSMC's management emphasized that the earthquake’s impact would be offset over the course of the year. The demand for high-powered chips, particularly to fuel the AI boom, is stronger than any seismic disruption. The company’s ability to bounce back from the quake underscores the resilience of its operations.
Investors appear confident as well, with TSMC’s shares up around 1.5% in early trading, signaling that the market trusts the company’s outlook and long-term growth potential despite the temporary setback.
Presented by Miso Robotics
Carmy’s tattooed arms may no longer be the most distinctive ones in the kitchen.
With fast food brands facing 150% annual turnover rates, they’re turning to Miso’s AI-powered kitchen robot, Flippy, to boost profits up to 4X and curb labor shortages.
Miso is already a leading force in kitchen AI and automation, with 150K+ hours of experience for brands like Jack in the Box.
Now, they’re manufacturing Flippy Fry Station – a robot 50% smaller and 2X faster than its predecessor. Its first small-scale production run sold out in seven days. And that sellout’s just the start.
In 2025, Miso’s ready to scale and targeting 170+ U.S. fast food brands in need – a potential $4B annual revenue opportunity. Invest1 in Miso today (and secure limited bonus shares).2
Advertiser's disclosures:
¹ The Company's Formula (Gx-03/Hexagen/Atopx) Has Received 510k Marketing Approval As A Medical Device Indicated For The Management Of Symptoms Related To Atopic Dermatitis/Eczema. The Formula Has Not Received Approval As A Drug For The Treatment Of Eczema Or Onychomycosis.
² A plan to IPO is no guarantee that an actual IPO will occur.
³ Please read the offering circular and related risks at StartEngine’s Turn Therapeutics webpage. This is a paid advertisement for Turn Therapeutics Regulation CF Offering. This Reg CF offering is made available through StartEngine Primary, LLC, member FINRA/SIPC.
Investing in private company securities is not suitable for all investors because it is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities.